Novel protein–inhibitor interactions in site 3 of Ca(2+)-bound S100B as discovered by X-ray crystallography

Structure-based drug discovery is under way to identify and develop small-molecule S100B inhibitors (SBiXs). Such inhibitors have therapeutic potential for treating malignant melanoma, since high levels of S100B downregulate wild-type p53 tumor suppressor function in this cancer. Computational and X...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Acta Crystallogr D Struct Biol
Prif Awduron: Cavalier, Michael C., Melville, Zephan, Aligholizadeh, Ehson, Raman, E. Prabhu, Yu, Wenbo, Fang, Lei, Alasady, Milad, Pierce, Adam D., Wilder, Paul T., MacKerell, Alexander D., Weber, David J.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: International Union of Crystallography 2016
Pynciau:
Research Papers
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4908867/
https://ncbi.nlm.nih.gov/pubmed/27303795
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1107/S2059798316005532
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg